WallStreetZenWallStreetZen

NASDAQ: TLSI
Trisalus Life Sciences Inc Stock Ownership - Who owns Trisalus Life Sciences?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Trisalus Life Sciences Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mary T. SzelaCEO and President2026-03-1715,944$3.85
$61.38kSell
Bryan F. CoxChief of Research2026-03-16579$4.12
$2.39kSell
Jodi DevlinChief of Clinical Operations2026-03-16273$4.12
$1.12kSell
Jennifer StevensChief Regulatory Officer2026-03-16774$4.12
$3.19kSell
Richard MarshakChief Commercial Officer2026-03-16419$4.12
$1.73kSell
Richard MarshakChief Commercial Officer2026-03-121,589$4.09
$6.50kSell
Bryan F. CoxChief of Research2026-03-121,467$4.09
$6.00kSell
Jodi DevlinChief of Clinical Operations2026-03-121,772$4.09
$7.25kSell
Jennifer StevensChief Regulatory Officer2026-03-121,552$4.09
$6.35kSell
Mary T. SzelaCEO and President2026-03-114,358$4.13
$18.00kSell

1 of 3

TLSI insiders have bought more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TLSI insiders and whales buy or sell their stock.

TLSI Shareholders

What type of owners hold Trisalus Life Sciences Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Equity Ab Frankenius11.40%6,989,748$31.73MInsider
Medtech Acquisition Sponsor LLC10.19%6,249,999$28.37MInsider
Mats Wahlstrom4.35%2,665,202$12.10MInsider
Kerry R. Hicks3.73%2,289,199$10.39MInsider
Nantahala Capital Management LLC3.38%2,070,827$9.40MInstitution
Blackrock Inc2.50%1,534,336$6.97MInstitution
Vanguard Group Inc2.50%1,530,707$6.95MInstitution
David J. Matlin2.07%1,271,944$5.77MInsider
Awm Investment Company Inc2.03%1,243,780$5.65MInstitution
Michael P. Stansky1.61%986,830$4.48MInsider

1 of 3

TLSI vs Medical Device Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TLSI18.61%38.37%Net BuyingNet Buying
SI32.11%58.97%Net BuyingNet Buying
MASS49.48%50.52%Net SellingNet Selling
SGHT35.92%57.04%Net BuyingNet Selling
PROF41.94%1.62%Net Buying
View Top Medical Device Stocks

Trisalus Life Sciences Stock Ownership FAQ

Who owns Trisalus Life Sciences?

Trisalus Life Sciences (NASDAQ: TLSI) is owned by 18.61% institutional shareholders, 38.37% Trisalus Life Sciences insiders, and 43.01% retail investors. Equity Ab Frankenius is the largest individual Trisalus Life Sciences shareholder, owning 6.99M shares representing 11.38% of the company. Equity Ab Frankenius's Trisalus Life Sciences shares are currently valued at $31.87M.

If you're new to stock investing, here's how to buy Trisalus Life Sciences stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.